Lorbrena Tablet, Film Coated
Product Images NDC 63539-927

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lorbrena (NDC 63539-927). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by U.s. Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Lorbrena 01)

Chemical structure of lorlatinib, the active ingredient in Lorbrena tablets. The diagram shows the molecular framework including various rings, substituents such as methyl groups, fluorine, and a cyano group, illustrating the compound's chemical configuration.*

FDA Label Image

Figure 1 (Lorbrena 02)

A Kaplan-Meier curve chart showing progression-free survival probability (%) over time (months) comparing Lorbrena (N=149) and Crizotinib (N=147). The solid line represents Lorbrena with a median survival not reached, while the dotted line represents Crizotinib with a median of 9.3 months. The chart includes hazard ratio (0.28), confidence interval (95% CI), and p-value (<0.0001). Numbers at risk are listed below the graph for each time point.*

FDA Label Image

Logo (Lorbrena 03)

FDA Label Image

Logo (Lorbrena 04)

FDA Label Image

Principal Display Panel (25 mg Tablet Bottle Label Sample)

Lorbrena 25 mg (lorlatinib) tablets label from Pfizer, distributed by U.S. Pharmaceuticals. The label includes storage instructions, dosage information, and indicates the package contains 30 film-coated tablets for oral use. The product is made in Ireland and is marked as a professional sample not for sale.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.